Product Program year 2025 Source: CMS Open Payments

Pemrydi Rtu

Drug Oncology

NDC 70121-2453-1

Open in the dashboard

General payments

$1,488

59 payments

Research payments

$0

0 payments

Through program year 2025, $1,488 in general payments and $0 in research payments were reported against Pemrydi Rtu (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $1,488 59

Breakdown

Who paid General payments · program year 2025
  1. Amneal Pharmaceuticals LLC $1,488 59 payments
Top recipients General payments · program year 2025
  1. Eric Schaefer Hematology & Oncology · Fayetteville, AR $95 6% · 1 payment
  2. Harsha Vyas Hematology & Oncology · Dublin, GA $89 6% · 1 payment
  3. Gary Kay Hematology & Oncology · Elk Grove Village, IL $89 6% · 1 payment
  4. Mohamed Sayed Ophthalmology · Gainesville, FL $30 2% · 1 payment
  5. Kelly Dewitt Radiation Oncology · La Mesa, CA $28 2% · 1 payment

The top 5 of 59 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $612 44% · 18 practitioners
  2. Physician Assistant $192 14% · 9 practitioners
  3. Medical Oncology Internal Medicine $138 10% · 7 practitioners
  4. Radiation Oncology Radiology $103 7% · 4 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $80 6% · 4 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $339 23% · 16 recipients
  2. California $322 22% · 14 recipients
  3. Arizona $157 11% · 8 recipients
  4. Arkansas $115 8% · 2 recipients
  5. Utah $108 7% · 4 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

59 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record